documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
48 rows where document_type = "Other" and posted_year = 2000 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2000-P-0151-0001 | FDA | Amend definition & standard of identity for parmesan cheese-CLOSED FDA-2000-P-0151 | FDA/DDM to Satori Food Corp. | Other | ACK-Acknowledgement Letter | 2000-12-29T05:00:00Z | 2000 | 12 | 2008-04-25T01:31:51Z | 0 | 0 | 09000064804d117d | |||
| FDA-2000-D-0598-0002 | FDA | Genotoxicity Studies (VICH GL23) FDA-2000-D-0598 | Guidance for Industry #116 Safety Studies for Veterinary Drug Residues in Human Food: Genotoxicity Studies VICH GL23; Draft Guidance | Other | Guidance | 2000-12-18T05:00:00Z | 2000 | 12 | 2013-01-23T05:00:00Z | 2013-01-24T03:08:44Z | 0 | 0 | 09000064804dd8b1 | ||
| FDA-2000-P-1559-0001 | FDA | Action Against Manufacturers of Garlic Supplements Misbranded-CLOSED FDA-2000-P-1559 | FDA/DDM to Center for Science in the Public Interest (CSPI) | Other | ACK-Acknowledgement Letter | 2000-12-13T05:00:00Z | 2000 | 12 | 2008-04-25T01:56:32Z | 0 | 0 | 09000064804f9287 | |||
| FDA-2000-D-0028-0002 | FDA | Channels trade policy commodities with methyl parathion FDA-2000-D-0028 | Guidance for Industry: Channels of Trade Policy for Commodities with Methyl Parathion Residues | Other | Guidance | 2000-11-30T05:00:00Z | 2000 | 11 | 2020-09-30T04:00:00Z | 2024-11-12T23:25:43Z | 1 | 0 | 09000064848a2c00 | ||
| FDA-1998-P-0046-0001 | FDA | Revoke determination that TSRH Pedicle Spinal Screw System-CLOSED FDA-1998-P-0046 | FDA/CDRH to Arnold Levin | Other | PDN-Petition Denial | 2000-11-08T05:00:00Z | 2000 | 11 | 2008-05-16T21:47:38Z | 0 | 0 | 090000648056e6a9 | |||
| FDA-2000-P-0212-0001 | FDA | Remove Unapproved Children's Fluoride Supplements from Mkt FDA-2000-P-0212 | New Jersey General Assembly - Citizen Petition | Other | CP-Citizen Petition | 2000-11-06T05:00:00Z | 2000 | 11 | 2010-08-12T19:47:56Z | 0 | 0 | 09000064804d4d1b | |||
| FDA-2000-P-0025-0003 | FDA | Classify cranial helment in class I,exempt from premarket-CLOSED FDA-2000-P-0025 | Petition Approval from FDA CDRH to American Orthotic & Prosthetic Association | Other | PAV-Petition Approval | 2000-10-31T05:00:00Z | 2000 | 10 | 2024-07-29T20:17:20Z | 0 | 0 | 09000064804aea11 | |||
| FDA-2000-P-0025-0002 | FDA | Classify cranial helment in class I,exempt from premarket-CLOSED FDA-2000-P-0025 | Petition Approval from FDA CDRH to American Orthotic & Prosthetic Association | Other | PAV-Petition Approval | 2000-10-31T05:00:00Z | 2000 | 10 | 2024-07-29T20:14:37Z | 0 | 0 | 09000064804aea10 | |||
| FDA-2000-P-0153-0001 | FDA | ANDA Suitability Petition for Ursodiol Oral Suspension-CLOSED FDA-2000-P-0153 | FDA/DDM to Lachman Consultant Services, Inc. | Other | ACK-Acknowledgement Letter | 2000-10-16T04:00:00Z | 2000 | 10 | 2008-04-25T01:45:52Z | 0 | 0 | 09000064804d1408 | |||
| FDA-2000-P-0096-0002 | FDA | Approve ANDA for Cefuroxime Axetil Products-CLOSED FDA-2000-P-0096 | FDA/DDM to Arnold & Porter | Other | ACK-Acknowledgement Letter | 2000-10-02T04:00:00Z | 2000 | 10 | 2008-04-25T01:01:16Z | 0 | 0 | 09000064804b8220 | |||
| FDA-2000-P-0096-0001 | FDA | Approve ANDA for Cefuroxime Axetil Products-CLOSED FDA-2000-P-0096 | FDA/DDM to Arnold & Porter | Other | ACK-Acknowledgement Letter | 2000-10-02T04:00:00Z | 2000 | 10 | 2008-04-25T01:01:17Z | 0 | 0 | 09000064804b8209 | |||
| FDA-2000-P-0214-0001 | FDA | ANDA for Sertraline Hydrochloride Capsules 25mg, 50mg & 100m-CLOSED FDA-2000-P-0214 | FDA/DDM to Lachman Consultant Services, Inc. | Other | ACK-Acknowledgement Letter | 2000-08-22T04:00:00Z | 2000 | 8 | 2008-04-25T01:14:23Z | 0 | 0 | 09000064804d4e50 | |||
| FDA-2000-P-0211-0003 | FDA | Amend the Product Insert and/or Label for Anthrax Vaccine Adsorbed FDA-2000-P-0211 | FDA/CBER to Mark S. Zaid | Other | LET-Letter | 2000-08-16T04:00:00Z | 2000 | 8 | 2008-04-25T01:47:40Z | 0 | 0 | 09000064804d4cd2 | |||
| FDA-2000-P-0211-0002 | FDA | Amend the Product Insert and/or Label for Anthrax Vaccine Adsorbed FDA-2000-P-0211 | FDA/CBER to Mark S. Zaid | Other | LET-Letter | 2000-08-16T04:00:00Z | 2000 | 8 | 2008-04-25T01:47:40Z | 0 | 0 | 09000064804d4cd0 | |||
| FDA-1980-N-0074-0071 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | HFD-560 | Other | MM-Memorandum of Meeting | 2000-08-09T04:00:00Z | 2000 | 8 | 2008-05-30T22:52:54Z | 0 | 0 | 09000064805bb4d0 | |||
| FDA-1978-N-0018-0439 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Memorandum of Meeting Between FDA/CDER and External Participants | Other | Memorandum | 2000-08-07T04:00:00Z | 2000 | 8 | 2019-08-06T19:13:07Z | 0 | 0 | 090000648055a6cc | |||
| FDA-1978-N-0018-0438 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Memorandum of Meeting Between FDA/CDER Participants and External Participants | Other | Memorandum | 2000-08-07T04:00:00Z | 2000 | 8 | 2019-08-06T18:35:41Z | 0 | 0 | 090000648055a6c9 | |||
| FDA-2020-D-1956-0001 | FDA | FDA-2020-D-1956 | Guidance for Industry: Action Levels for Poisonous or Deleterious Substances in Human Food and Animal Feed | Other | Guidance | 2000-07-31T04:00:00Z | 2000 | 7 | 2020-09-21T04:00:00Z | 2024-11-12T23:24:59Z | 1 | 0 | 090000648486938e | ||
| FDA-2000-P-0024-0002 | FDA | ANDA Suitability for Hydrocodone Bitartrate/Acetaminophen-CLOSED FDA-2000-P-0024 | FDA/DDM to Pharmaceutical Associates, Inc | Other | ACK-Acknowledgement Letter | 2000-07-26T04:00:00Z | 2000 | 7 | 2008-04-25T01:13:49Z | 0 | 0 | 09000064804ae9ff | |||
| FDA-1999-H-0116-0001 | FDA | Civil Money Penalties;Westfield Food Mart Inc,d/b/a Shell FDA-1999-H-0116 | Office of Tobacco Programs | Other | LET-Letter | 2000-07-18T04:00:00Z | 2000 | 7 | 2009-07-07T18:08:47Z | 0 | 0 | 09000064804ae912 | |||
| FDA-1999-H-0143-0001 | FDA | Civil Money Penalties; Triple V Inc,d/b/a Country Market FDA-1999-H-0143 | Office of Tobacco Programs | Other | LET-Letter | 2000-07-18T04:00:00Z | 2000 | 7 | 2009-07-07T18:13:38Z | 0 | 0 | 09000064804aef05 | |||
| FDA-1999-H-0018-0001 | FDA | Civil Money Penalties; Carlie C's IGA Inc FDA-1999-H-0018 | Office of Tobacco Programs | Other | LET-Letter | 2000-07-12T04:00:00Z | 2000 | 7 | 2009-07-07T14:12:12Z | 0 | 0 | 09000064804a5a99 | |||
| FDA-1999-H-0017-0001 | FDA | Civil Money Penalties;R.G. Stocks & Son, Inc,d/b/a Stocks FDA-1999-H-0017 | Office of Tobacco Programs | Other | LET-Letter | 2000-07-12T04:00:00Z | 2000 | 7 | 2009-07-07T13:29:31Z | 0 | 0 | 09000064804a5a88 | |||
| FDA-1999-H-0017-0002 | FDA | Civil Money Penalties;R.G. Stocks & Son, Inc,d/b/a Stocks FDA-1999-H-0017 | FDA/CDRH/GCF | Other | CR-Correction | 2000-07-12T04:00:00Z | 2000 | 7 | 2009-07-07T14:01:38Z | 0 | 0 | 09000064804a5a91 | |||
| FDA-1999-H-0054-0001 | FDA | Civil Money Penalties;Eckerd Corp,d/b/a Eckerd Drug #8608 FDA-1999-H-0054 | Office of Tobacco Programs | Other | LET-Letter | 2000-07-07T04:00:00Z | 2000 | 7 | 2009-07-07T14:13:40Z | 0 | 0 | 09000064804a61a3 | |||
| FDA-1980-N-0074-0070 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | HFD-560 | Other | MM-Memorandum of Meeting | 2000-06-28T04:00:00Z | 2000 | 6 | 2008-05-30T22:53:02Z | 0 | 0 | 09000064805bb4cf | |||
| FDA-1999-H-0071-0001 | FDA | Civil Money Penalty; Dong Seo Shin d/b/a East 4th Avenue Food Mart FDA-1999-H-0071 | HHS/FDA/CDER Notice of Correction of Store Name - Correction | Other | CR-Correction | 2000-06-15T04:00:00Z | 2000 | 6 | 2013-07-27T20:58:49Z | 0 | 0 | 09000064804a6880 | |||
| FDA-1995-S-0039-0320 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | Report | 2000-05-21T04:00:00Z | 2000 | 5 | 2014-02-28T05:00:00Z | 2016-09-30T14:25:01Z | 0 | 0 | 090000648055c40f | ||
| FDA-1980-N-0074-0069 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | HFD-560, CDER HFD-105 and Warner Lambert | Other | MM-Memorandum of Meeting | 2000-04-27T04:00:00Z | 2000 | 4 | 2008-05-30T22:52:47Z | 0 | 0 | 09000064805bb4c7 | |||
| FDA-1995-S-0039-0169 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report (outside of agency unless indicated) | 2000-04-19T04:00:00Z | 2000 | 4 | 2009-02-05T05:00:00Z | 2016-09-30T14:23:12Z | 0 | 0 | 090000648055c40d | ||
| FDA-1995-S-0039-0168 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report (outside of agency unless indicated) | 2000-04-18T04:00:00Z | 2000 | 4 | 2009-02-05T05:00:00Z | 2016-09-30T14:23:11Z | 0 | 0 | 090000648055c40b | ||
| FDA-1980-P-0012-0014 | FDA | Showlasers model LP1-CLOSED FDA-1980-P-0012 | Approval for Variance from FDA/CDRH to Showlasers, Inc. (duplicate) | Other | Approval for Variance (VRA) | 2000-04-13T04:00:00Z | 2000 | 4 | 2021-02-24T17:53:01Z | 0 | 0 | 09000064805b926d | |||
| FDA-1980-P-0012-0013 | FDA | Showlasers model LP1-CLOSED FDA-1980-P-0012 | Approval for Variance from FDA/CDRH to Showlasers, Inc. | Other | Approval for Variance (VRA) | 2000-04-13T04:00:00Z | 2000 | 4 | 2021-02-24T17:51:26Z | 0 | 0 | 09000064805b926c | |||
| FDA-2000-P-0024-0001 | FDA | ANDA Suitability for Hydrocodone Bitartrate/Acetaminophen-CLOSED FDA-2000-P-0024 | FDA/DDM to Pharmaceutical Associates Inc | Other | ACK-Acknowledgement Letter | 2000-04-07T04:00:00Z | 2000 | 4 | 2008-04-25T01:13:49Z | 0 | 0 | 09000064804ae9e8 | |||
| FDA-1999-P-0126-0006 | FDA | Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 | FDA/CDER to Pharmacia & Upjohn | Other | LET-Letter | 2000-04-06T04:00:00Z | 2000 | 4 | 2008-04-25T00:19:51Z | 0 | 0 | 09000064804ae9f2 | |||
| FDA-1999-P-0059-0002 | FDA | Reg/Guide to Label Medical Devices contain'g Phthalate Plasticizers-CLOSED FDA-1999-P-0059 | FDA/CDRH to Sanford J. Lewis | Other | LET-Letter | 2000-04-06T04:00:00Z | 2000 | 4 | 2008-04-25T00:13:57Z | 0 | 0 | 09000064804a6715 | |||
| FDA-1986-V-0022-0009 | FDA | Ion laser technology series ILT 5000 Demo unit FDA-1986-V-0022 | Variance Approval Letter from FDA CDRH to California Technical Associates | Other | Approval for Variance (VRA) | 2000-03-22T05:00:00Z | 2000 | 3 | 2023-01-18T18:47:01Z | 0 | 0 | 090000648050dd45 | |||
| FDA-1991-V-0023-0005 | FDA | Las Vegas laser rental light shows. FDA-1991-V-0023 | Variance Approval Letter from FDA CDRH to Las Vegas Laser Rental | Other | Approval for Variance (VRA) | 2000-03-22T05:00:00Z | 2000 | 3 | 2023-10-13T12:19:38Z | 0 | 0 | 0900006480528680 | |||
| FDA-2000-P-0025-0001 | FDA | Classify cranial helment in class I,exempt from premarket-CLOSED FDA-2000-P-0025 | Acknowledgment Letter from FDA DMB to American Orthotic & Prosthetic Association | Other | ACK-Acknowledgement Letter | 2000-03-14T05:00:00Z | 2000 | 3 | 2024-07-29T20:12:00Z | 0 | 0 | 09000064804aea0c | |||
| FDA-2000-D-1542-0002 | FDA | Content/Format of NDA/ANDA for Certain Positron Emission FDA-2000-D-1542 | Draft Guidance for Industry on the Content and Format of New Drug Applications and Abbreviated New Drug Applications for Certain Positron Emission Tomography Drug Products - Guidance | Other | GDL-Guidance (Supporting and Related Materials) | 2000-03-10T19:46:00Z | 2000 | 3 | 2000-03-10T05:00:00Z | 2019-10-17T17:11:55Z | 0 | 0 | 09000064804f9073 | ||
| FDA-1995-S-0039-0167 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report (outside of agency unless indicated) | 2000-02-17T05:00:00Z | 2000 | 2 | 2009-02-05T05:00:00Z | 2016-09-30T14:23:11Z | 0 | 0 | 090000648055c402 | ||
| FDA-1995-S-0039-0166 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report (outside of agency unless indicated) | 2000-02-17T05:00:00Z | 2000 | 2 | 2009-02-05T05:00:00Z | 2016-09-30T14:23:11Z | 0 | 0 | 090000648055c3fe | ||
| FDA-2000-P-0211-0001 | FDA | Amend the Product Insert and/or Label for Anthrax Vaccine Adsorbed FDA-2000-P-0211 | FDA/DDM to Mark S. Zaid | Other | ACK-Acknowledgement Letter | 2000-02-16T05:00:00Z | 2000 | 2 | 2008-04-25T01:47:40Z | 0 | 0 | 09000064804d4c9f | |||
| FDA-1998-P-0018-0003 | FDA | Drug products containing oxycodone hydrocloride tablet suitable-CLOSED FDA-1998-P-0018 | Correction to Citizen Petition from King & Spalding | Other | Correction(s) | 2000-02-14T05:00:00Z | 2000 | 2 | 2024-07-12T16:52:34Z | 0 | 0 | 0900006480563c52 | |||
| FDA-1999-D-0061-0003 | FDA | Testing Orthopedic Implants with Metallic Plasma Sprayed FDA-1999-D-0061 | HFZ-220 | Other | NAD-Notice of Availability of Data | 2000-02-03T05:00:00Z | 2000 | 2 | 2024-11-07T21:52:50Z | 1 | 0 | 09000064804a6774 | |||
| FDA-1996-N-0006-0003 | FDA | Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 | Memorandum of Meeting FDA with European Sunscreen Manufacturers re Sunscreen Monograph/Foreign Marketing October 28, 1998 | Other | Memorandum | 2000-01-20T05:00:00Z | 2000 | 1 | 2015-03-20T16:01:26Z | 0 | 0 | 09000064804f9943 | |||
| FDA-2020-D-1957-0001 | FDA | FDA-2020-D-1957 | CPG Sec. 300.200 - Reconditioners/Rebuilders of Medical Devices - Revoked-Deletion 01/04/2000 | Other | Guidance | 2000-01-03T05:00:00Z | 2000 | 1 | 2020-09-21T04:00:00Z | 2024-11-06T23:39:28Z | 1 | 0 | 0900006484869390 | ||
| FDA-1995-S-0039-0157 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Report from FDA/CFSAN | Other | RPT-Report (outside of agency unless indicated) | 2000-01-01T05:00:00Z | 2000 | 1 | 2009-01-02T05:00:00Z | 2016-09-30T14:23:07Z | 0 | 0 | 090000648055c3f8 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);